BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim WR, Lake JR, Smith JM, Skeans MA, Schladt DP, Edwards EB, Harper AM, Wainright JL, Snyder JJ, Israni AK, Kasiske BL. OPTN/SRTR 2013 Annual Data Report: liver. Am J Transplant. 2015;15 Suppl 2:1-28. [PMID: 25626341 DOI: 10.1111/ajt.13197] [Cited by in Crossref: 230] [Cited by in F6Publishing: 184] [Article Influence: 32.9] [Reference Citation Analysis]
Number Citing Articles
1 Kakisaka K, Suzuki Y, Abe H, Watanabe T, Yusa K, Sato H, Takikawa Y. Early identification using the referral system prolonged the time to onset for hepatic encephalopathy after diagnosing severe acute liver injury. Sci Rep 2020;10:17280. [PMID: 33057105 DOI: 10.1038/s41598-020-74466-2] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Sasaki K, Firl DJ, Mcvey JC, Schold JD, Iuppa G, Diago Uso T, Fujiki M, Aucejo FN, Quintini C, Eghetsad B, Miller CM, Hashimoto K. Elevated Risk of Split‐Liver grafts in adult liver Transplantation: Statistical Artifact or Nature of the Beast? Liver Transpl 2019;25:741-51. [DOI: 10.1002/lt.25409] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
3 Santivasi WL, Strand JJ, Mueller PS, Beckman TJ. The Organ Transplant Imperative. Mayo Clinic Proceedings 2017;92:940-6. [DOI: 10.1016/j.mayocp.2017.03.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
4 Yee ML, Tan HH. Use of everolimus in liver transplantation. World J Hepatol 2017; 9(23): 990-1000 [PMID: 28878864 DOI: 10.4254/wjh.v9.i23.990] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
5 Rao S, Ghanta M, Moritz MJ, Constantinescu S. Long-Term Functional Recovery, Quality of Life, and Pregnancy After Solid Organ Transplantation. Medical Clinics of North America 2016;100:613-29. [DOI: 10.1016/j.mcna.2016.01.010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
6 Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yagi S, Hammad A, Okajima H, Uemoto S. Proposal of Muscle-MELD Score, Including Muscularity, for Prediction of Mortality After Living Donor Liver Transplantation. Transplantation 2016;100:2416-23. [DOI: 10.1097/tp.0000000000001413] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Machicao VI. Model for End-Stage Liver Disease–Sodium Score. Clinics in Liver Disease 2017;21:275-87. [DOI: 10.1016/j.cld.2016.12.014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
8 Suraweera D, Jimenez M, Viramontes M, Jamal N, Grotts J, Elashoff D, Lee EW, Saab S. Age-related Morbidity and Mortality After Transjugular Intrahepatic Portosystemic Shunts. Journal of Clinical Gastroenterology 2017;51:360-3. [DOI: 10.1097/mcg.0000000000000541] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
9 Lee JG, Lee J, Lee JJ, Song SH, Ju MK, Choi GH, Kim MS, Choi JS, Kim SI, Joo DJ. Efficacy of rabbit anti-thymocyte globulin for steroid-resistant acute rejection after liver transplantation. Medicine (Baltimore) 2016;95:e3711. [PMID: 27281070 DOI: 10.1097/MD.0000000000003711] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 2.2] [Reference Citation Analysis]
10 Fisher RA. Living donor liver transplantation: eliminating the wait for death in end-stage liver disease? Nat Rev Gastroenterol Hepatol. 2017;14:373-382. [PMID: 28196987 DOI: 10.1038/nrgastro.2017.2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 5.6] [Reference Citation Analysis]
11 Robertson JD. Pediatric transplantation: preventing thrombosis. J Thromb Haemost. 2015;13 Suppl 1:S351-S361. [PMID: 26149047 DOI: 10.1111/jth.12968] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
12 Udomsin K, Lapisatepun W, Chotirosniramit A, Sandhu T, Ariyakachon V, Lorsomradee S, Boonsri S, Chanthima P, Lapisatepun W, Kaewpoowat Q, Ko-Iam W, Mueangin S, Chongruksut W, Junrungsee S. Adult-to-Adult Living Donor Liver Transplantation: Postoperative Outcomes and Quality of Life in Liver Donors: First Report in Thailand. Transplant Proc 2019;51:2761-5. [PMID: 31493914 DOI: 10.1016/j.transproceed.2019.03.080] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Hsu EK, Mazariegos GV. Global lessons in graft type and pediatric liver allocation: A path toward improving outcomes and eliminating wait-list mortality. Liver Transpl 2017;23:86-95. [PMID: 27706890 DOI: 10.1002/lt.24646] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 6.8] [Reference Citation Analysis]
14 Ali AH, Lindor KD. Obeticholic acid for the treatment of primary biliary cholangitis. Expert Opin Pharmacother. 2016;17:1809-1815. [PMID: 27468093 DOI: 10.1080/14656566.2016.1218471] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
15 Kathpalia P, Smith A, Lai JC. Underutilization of palliative care services in the liver transplant population. World J Transplant 2016; 6(3): 594-598 [PMID: 27683638 DOI: 10.5500/wjt.v6.i3.594] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
16 Hu Z, Zhou J, Li Z, Xiang J, Zhang Q, Yan S, Wu J, Zhang M, Wang W, Zheng S. Variant outcomes of liver transplantation for hepatitis C virus patients in different age categories: impact of the model for end-stage liver disease score. J Hepatobiliary Pancreat Sci 2017;24:206-16. [PMID: 28107613 DOI: 10.1002/jhbp.435] [Reference Citation Analysis]
17 Saab S, Rheem J, Jimenez M, Bau S, Choi G, Durazo F, El Kabany M, Han S, Farid A, Jamal N, Grotts J, Elashoff D, Busuttil RW. Curing Hepatitis C in Liver Transplant Recipients Is Associated with Changes in Immunosuppressant Use. J Clin Transl Hepatol 2016;4:32-8. [PMID: 27047770 DOI: 10.14218/JCTH.2016.00001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
18 Joshi N, Kopec AK, Ray JL, Cline-Fedewa H, Nawabi A, Schmitt T, Nault R, Zacharewski TR, Rockwell CE, Flick MJ, Luyendyk JP. Fibrin deposition following bile duct injury limits fibrosis through an αMβ2-dependent mechanism. Blood 2016;127:2751-62. [PMID: 26921287 DOI: 10.1182/blood-2015-09-670703] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
19 D'Avola D, Cuervas-Mons V, Martí J, Ortiz de Urbina J, Lladó L, Jimenez C, Otero E, Suarez F, Rodrigo JM, Gómez MA, Fraga E, Lopez P, Serrano MT, Rios A, Fábrega E, Herrero JI. Cardiovascular morbidity and mortality after liver transplantation: The protective role of mycophenolate mofetil. Liver Transpl 2017;23:498-509. [PMID: 28160394 DOI: 10.1002/lt.24738] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 6.2] [Reference Citation Analysis]
20 Ko YC, Tsai HI, Lee CW, Lin JR, Lee WC, Yu HP. A nomogram for prediction of early allograft dysfunction in living donor liver transplantation. Medicine (Baltimore) 2020;99:e22749. [PMID: 33080739 DOI: 10.1097/MD.0000000000022749] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Kalisvaart M, de Haan JE, Hesselink DA, Polak WG, Hansen BE, Ijzermans JNM, Gommers D, Metselaar HJ, de Jonge J. The postreperfusion syndrome is associated with acute kidney injury following donation after brain death liver transplantation. Transpl Int 2017;30:660-9. [DOI: 10.1111/tri.12891] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
22 Mah A, Hull MW, DeBeck K, Milloy MJ, Dobrer S, Nosova E, Wood E, Kerr T, Hayashi K. Knowledge of hepatitis C and treatment willingness amongst people who inject drugs in an era of direct acting antivirals. Int J Drug Policy 2017;47:137-43. [PMID: 28347636 DOI: 10.1016/j.drugpo.2017.02.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
23 Ceresa CDL, Nasralla D, Jassem W. Normothermic Machine Preservation of the Liver: State of the Art.Curr Transplant Rep. 2018;5:104-110. [PMID: 29564207 DOI: 10.1007/s40472-018-0186-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
24 Saab S, Greenberg A, Li E, Bau SN, Durazo F, El-Kabany M, Han S, Busuttil RW. Sofosbuvir and simeprevir is effective for recurrent hepatitis C in liver transplant recipients. Liver Int. 2015;35:2442-2447. [PMID: 25913321 DOI: 10.1111/liv.12856] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 5.4] [Reference Citation Analysis]
25 Horvat N, Marcelino ASZ, Horvat JV, Yamanari TR, Batista Araújo-Filho JA, Panizza P, Seda-Neto J, Antunes da Fonseca E, Carnevale FC, Mendes de Oliveira Cerri L, Chapchap P, Cerri GG. Pediatric Liver Transplant: Techniques and Complications. Radiographics 2017;37:1612-31. [PMID: 29019744 DOI: 10.1148/rg.2017170022] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.8] [Reference Citation Analysis]
26 Alobaidi R, Anton N, Cave D, Moez EK, Joffe AR. Predicting early outcomes of liver transplantation in young children: The EARLY study. World J Hepatol 2018; 10(1): 62-72 [PMID: 29399279 DOI: 10.4254/wjh.v10.i1.62] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
27 Dolgin NH, Movahedi B, Anderson FA, Brüggenwirth IM, Martins PN, Bozorgzadeh A. Impact of recipient functional status on 1-year liver transplant outcomes. World J Transplant 2019; 9(7): 145-157 [PMID: 31850158 DOI: 10.5500/wjt.v9.i7.145] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
28 Hobeika MJ, Miller CM, Pruett TL, Gifford KA, Locke JE, Cameron AM, Englesbe MJ, Kuhr CS, Magliocca JF, McCune KR, Mekeel KL, Pelletier SJ, Singer AL, Segev DL. PROviding Better ACcess To ORgans: A comprehensive overview of organ-access initiatives from the ASTS PROACTOR Task Force. Am J Transplant 2017;17:2546-58. [PMID: 28742951 DOI: 10.1111/ajt.14441] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
29 Hartsock JA, Ivy SS, Helft PR. Liver Allocation to Non-U.S. Citizen Non-U.S. Residents: An Ethical Framework for a Last-in-Line Approach. Am J Transplant 2016;16:1681-7. [DOI: 10.1111/ajt.13674] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
30 Sapisochin G, Bruix J. Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches. Nat Rev Gastroenterol Hepatol. 2017;14:203-217. [PMID: 28053342 DOI: 10.1038/nrgastro.2016.193] [Cited by in Crossref: 146] [Cited by in F6Publishing: 145] [Article Influence: 29.2] [Reference Citation Analysis]
31 Elwir S, Thompson J, Amateau SK, Trikudanathan G, Attam R, Hassan M, Kandaswamy R, Pruett T, Lake J, Chinnakotla S, Freeman ML, Arain MA. Endoscopic Management of Biliary Leaks and Strictures After Living Donor Liver Transplantation: Optimizing Techniques for Successful Management. Dig Dis Sci 2017;62:244-52. [PMID: 27866300 DOI: 10.1007/s10620-016-4367-z] [Cited by in Crossref: 5] [Article Influence: 0.8] [Reference Citation Analysis]
32 Yong JN, Lim WH, Ng CH, Tan DJH, Xiao J, Tay PWL, Lin SY, Syn N, Chew N, Nah B, Dan YY, Huang DQ, Tan EXX, Sanyal AJ, Noureddin M, Siddiqui MS, Muthiah MD. Outcomes of Nonalcoholic Steatohepatitis After Liver Transplantation: An Updated Meta-Analysis and Systematic Review. Clin Gastroenterol Hepatol 2021:S1542-3565(21)01226-X. [PMID: 34801743 DOI: 10.1016/j.cgh.2021.11.014] [Reference Citation Analysis]
33 Soldera J, Camazzola F, Rodríguez S, Brandão A. Dobutamine stress echocardiography, myocardial perfusion scintigraphy, invasive coronary angiography, and post-liver transplantation events: Systematic review and meta-analysis. Clin Transplant 2018;32:e13222. [PMID: 29436036 DOI: 10.1111/ctr.13222] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
34 Grąt M, Wronka KM, Patkowski W, Stypułkowski J, Grąt K, Krasnodębski M, Masior Ł, Lewandowski Z, Krawczyk M. Effects of Donor Age and Cold Ischemia on Liver Transplantation Outcomes According to the Severity of Recipient Status. Dig Dis Sci 2016;61:626-35. [PMID: 26499986 DOI: 10.1007/s10620-015-3910-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
35 Emond JC. Live Donor Liver Transplantation: An International Perspective. Transplantation 2016;100:1182-3. [PMID: 27203591 DOI: 10.1097/TP.0000000000001220] [Reference Citation Analysis]
36 Soldera J, Camazzola F, Rodríguez S, Brandão A. Cardiac stress testing and coronary artery disease in liver transplantation candidates: Meta-analysis. World J Hepatol 2018; 10(11): 877-886 [PMID: 30533188 DOI: 10.4254/wjh.v10.i11.877] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
37 Calik Basaran N, Ascioglu S. Epidemiology and management of healthcare-associated bloodstream infections in non-neutropenic immunosuppressed patients: a review of the literature. Ther Adv Infect Dis 2017;4:171-91. [PMID: 29662673 DOI: 10.1177/2049936117733394] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
38 Santos CA, Hotchkiss RS, Chapman WC, Olsen MA. Epidemiology of Bloodstream Infections in a Multicenter Retrospective Cohort of Liver Transplant Recipients. Transplant Direct 2016;2:e67. [PMID: 27458606 DOI: 10.1097/TXD.0000000000000573] [Cited by in Crossref: 9] [Article Influence: 1.5] [Reference Citation Analysis]
39 Lin CM, Plenter RJ, Coulombe M, Gill RG. Interferon Gamma and Contact-dependent Cytotoxicity Are Each Rate Limiting for Natural Killer Cell-Mediated Antibody-dependent Chronic Rejection. Am J Transplant 2016;16:3121-30. [PMID: 27163757 DOI: 10.1111/ajt.13865] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
40 Singh S, Venkatesh SK, Keaveny A, Adam S, Miller FH, Asbach P, Godfrey EM, Silva AC, Wang Z, Murad MH, Asrani SK, Lomas DJ, Ehman RL. Diagnostic accuracy of magnetic resonance elastography in liver transplant recipients: A pooled analysis. Ann Hepatol 2016;15:363-76. [PMID: 27049490 DOI: 10.5604/16652681.1198808] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
41 Qu Z, Krauth C, Amelung VE, Kaltenborn A, Gwiasda J, Harries L, Beneke J, Schrem H, Liersch S. Decision modelling for economic evaluation of liver transplantation. World J Hepatol 2018; 10(11): 837-848 [PMID: 30533184 DOI: 10.4254/wjh.v10.i11.837] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Su CW, Yang YY, Lin HC. Impact of etiological treatment on prognosis. Hepatol Int 2018;12:56-67. [PMID: 28702738 DOI: 10.1007/s12072-017-9807-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
43 Olthoff KM, Smith AR, Abecassis M, Baker T, Emond JC, Berg CL, Beil CA, Burton JR Jr, Fisher RA, Freise CE, Gillespie BW, Grant DR, Humar A, Kam I, Merion RM, Pomfret EA, Samstein B, Shaked A. Defining long-term outcomes with living donor liver transplantation in North America. Ann Surg 2015;262:465-75; discussion 473-5. [PMID: 26258315 DOI: 10.1097/SLA.0000000000001383] [Cited by in Crossref: 80] [Cited by in F6Publishing: 14] [Article Influence: 11.4] [Reference Citation Analysis]
44 Huaman MA, Vilchez V, Mei X, Shah MB, Daily MF, Berger J, Gedaly R. Decreased graft survival in liver transplant recipients of donors with positive blood cultures: a review of the United Network for Organ Sharing dataset. Transpl Int 2017;30:558-65. [PMID: 27896854 DOI: 10.1111/tri.12900] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
45 van Rijn R, van den Berg AP, Erdmann JI, Heaton N, van Hoek B, de Jonge J, Leuvenink HGD, Mahesh SVK, Mertens S, Monbaliu D, Muiesan P, Perera MTPR, Polak WG, Rogiers X, Troisi RI, de Vries Y, Porte RJ. Study protocol for a multicenter randomized controlled trial to compare the efficacy of end-ischemic dual hypothermic oxygenated machine perfusion with static cold storage in preventing non-anastomotic biliary strictures after transplantation of liver grafts donated after circulatory death: DHOPE-DCD trial. BMC Gastroenterol 2019;19:40. [PMID: 30866837 DOI: 10.1186/s12876-019-0956-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 7.3] [Reference Citation Analysis]
46 Simpson SJ, Le Couteur DG, James DE, George J, Gunton JE, Solon-Biet SM, Raubenheimer D. The Geometric Framework for Nutrition as a tool in precision medicine. Nutr Healthy Aging 2017;4:217-26. [PMID: 29276791 DOI: 10.3233/NHA-170027] [Cited by in Crossref: 36] [Cited by in F6Publishing: 18] [Article Influence: 7.2] [Reference Citation Analysis]
47 Koh C, Dubey P, Han MAT, Walter PJ, Garraffo HM, Surana P, Southall NT, Borochov N, Uprichard SL, Cotler SJ, Etzion O, Heller T, Dahari H, Liang TJ. A randomized, proof-of-concept clinical trial on repurposing chlorcyclizine for the treatment of chronic hepatitis C. Antiviral Res 2019;163:149-55. [PMID: 30711416 DOI: 10.1016/j.antiviral.2019.01.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
48 Yovchev MI, Locker J, Oertel M. Biliary fibrosis drives liver repopulation and phenotype transition of transplanted hepatocytes. J Hepatol 2016;64:1348-57. [PMID: 26855174 DOI: 10.1016/j.jhep.2016.01.036] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
49 D'Alessandro MCO, Gomes AD, Morais JF, Mizubuti YGG, Silva TAD, Fernandes SM, Mendes LL, Correia MITD, Generoso SV. SHORT-TERM EFFECT OF WHEY PROTEIN SUPPLEMENTATION ON THE QUALITY OF LIFE OF PATIENTS WAITING FOR LIVER TRANSPLANTATION: A DOUBLE BLINDED RANDOMIZED CLINICAL TRIAL. Arq Bras Cir Dig 2021;34:e1596. [PMID: 34669886 DOI: 10.1590/0102-672020210002e1596] [Reference Citation Analysis]
50 Fakhar N, Nikeghbalian S, Kazemi K, Shamsayeefar AR, Gholami S, Kasraianfard A, Malek-Hosseini SA. Transplantation of Deceased Donor Livers With Elevated Levels of Serum Transaminases at Shiraz Transplant Center. Hepat Mon 2016;16:e40140. [PMID: 27882068 DOI: 10.5812/hepatmon.40140] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
51 Mogalian E, Brainard DM, Osinusi A, Moorehead L, Murray B, Ling KHJ, Perry R, Curtis C, Lawitz E, Lasseter K, Marbury T, Mathias A. Pharmacokinetics and Safety of Velpatasvir and Sofosbuvir/Velpatasvir in Subjects with Hepatic Impairment. Clin Pharmacokinet 2018;57:1449-57. [DOI: 10.1007/s40262-018-0645-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
52 Naik KB, Hawkins CM, Gill AE, Gupta NA. Clinical Efficacy of Percutaneous Transhepatic Portal Vein Angioplasty for Late-onset Portal Vein Stenosis in Pediatric Liver Transplant Patients. Transplantation 2018;102:e282-7. [DOI: 10.1097/tp.0000000000002138] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
53 Kalra A, Wedd JP, Biggins SW. Changing prioritization for transplantation: MELD-Na, hepatocellular carcinoma exceptions, and more. Curr Opin Organ Transplant. 2016;21:120-126. [PMID: 26825358 DOI: 10.1097/mot.0000000000000281] [Cited by in Crossref: 30] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
54 Bhat M, Wyse JM, Moodie E, Ghali P, Hilzenrat N, Wong P, Deschenes M. Prevalence and predictors of sleep disturbance among liver diseases in long-term transplant survivors. Can J Gastroenterol Hepatol 2015;29:440-4. [PMID: 26176212 DOI: 10.1155/2015/359640] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
55 Finotti M, Romano M, Auricchio P, Scopelliti M, Brizzolari M, Grossi U, Piccino M, Benvenuti S, Morana G, Cillo U, Zanus G. Target Therapies for NASH/NAFLD: From the Molecular Aspect to the Pharmacological and Surgical Alternatives. J Pers Med 2021;11:499. [PMID: 34199535 DOI: 10.3390/jpm11060499] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
56 Shonaka T, Matsuno N, Obara H, Yoshikawa R, Nishikawa Y, Gouchi M, Otani M, Takahashi H, Azuma H, Sakai H, Furukawa H. Application of Perfusate With Human-Derived Oxygen Carrier Solution Under Subnormothermic Machine Perfusion for Donation After Cardiac Death Liver Grafts in Pigs. Transplant Proc 2018;50:2821-5. [PMID: 30401404 DOI: 10.1016/j.transproceed.2018.02.184] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
57 Smith HL, Chung RT, Mantry P, Chapman W, Curry MP, Schiano TD, Boucher E, Cheslock P, Wang Y, Molrine DC. Prevention of allograft HCV recurrence with peri-transplant human monoclonal antibody MBL-HCV1 combined with a single oral direct-acting antiviral: A proof-of-concept study. J Viral Hepat 2017;24:197-206. [PMID: 28127942 DOI: 10.1111/jvh.12632] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
58 Moussaoui D, Toso C, Nowacka A, McLin VA, Bednarkiewicz M, Andres A, Berney T, Majno P, Wildhaber BE. Early complications after liver transplantation in children and adults: Are split grafts equal to each other and equal to whole livers? Pediatr Transplant. 2017;21. [PMID: 28261944 DOI: 10.1111/petr.12908] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
59 Singh A, Fritze D, Mansouri M, Lopez R, Poordad F, Lawitz E, Cigarroa F, Halff G, Alkhouri N. Characteristics and Outcomes of Liver Transplantation for Primary Biliary Cholangitis in Young Patients: Analysis of the United Network for Organ Sharing Database. Transplantation 2019;103:1191-8. [PMID: 30376552 DOI: 10.1097/TP.0000000000002501] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
60 Weiner J, Griesemer A, Island E, Lobritto S, Martinez M, Selvaggi G, Lefkowitch J, Velasco M, Tryphonopoulos P, Emond J, Tzakis A, Kato T. Longterm outcomes of auxiliary partial orthotopic liver transplantation in preadolescent children with fulminant hepatic failure: LT in Pre-Adolescent Children. Liver Transpl 2016;22:485-94. [DOI: 10.1002/lt.24361] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
61 Vinson AJ, Gala-lopez B, Tennankore K, Kiberd B. The Use of Donation After Circulatory Death Organs for Simultaneous Liver-kidney Transplant: To DCD or Not to DCD? Transplantation 2019;103:1159-67. [DOI: 10.1097/tp.0000000000002434] [Cited by in Crossref: 6] [Article Influence: 2.0] [Reference Citation Analysis]
62 Saab S, Challita Y, Chen PH, Jimenez MA, Lee AD, Saab EG, Ahn T, Choi G, Durazo FA, El-Kabany MM, Han SB, Grotts J, Agopian VG, Busuttil RW. Elimination of Hepatitis C in Liver Transplant Recipients. J Clin Transl Hepatol 2018;6:247-50. [PMID: 30271735 DOI: 10.14218/JCTH.2017.00079] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
63 Shaffer AA, Thomas AG, Bowring MG, Van Pilsum Rasmussen SE, Cash A, Kucirka LM, Alqahtani SA, Gurakar A, Sulkowski MS, Cameron AM, Segev DL, Durand CM. Changes in practice and perception of hepatitis C and liver transplantation: Results of a national survey. Transpl Infect Dis 2018;20:e12982. [PMID: 30144258 DOI: 10.1111/tid.12982] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
64 Wei Q, Nemdharry RS, Zhuang RZ, Li J, Ling Q, Wu J, Shen T, Zhou L, Xie HY, Zhang M, Xu X, Zheng SS. A good prognostic predictor for liver transplantation recipients with benign end-stage liver cirrhosis. Hepatobiliary Pancreat Dis Int 2017;16:164-8. [PMID: 28381380 DOI: 10.1016/s1499-3872(16)60187-x] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
65 Chen YY, Li H, Xu BY, Zheng X, Li BL, Wang XB, Huang Y, Gao YH, Qian ZP, Liu F, Lu XB, Shang J, Li H, Wang SY, Zhang YH, Meng ZJ; Chinese Chronic Liver Failure (CLIF) Consortium. Plasma Exchange-Based Non-bioartificial Liver Support System Improves the Short-Term Outcomes of Patients With Hepatitis B Virus-Associated Acute-on-Chronic Liver Failure: A Multicenter Prospective Cohort Study. Front Med (Lausanne) 2021;8:779744. [PMID: 34869500 DOI: 10.3389/fmed.2021.779744] [Reference Citation Analysis]
66 Traino HM, Molisani AJ, Siminoff LA. Regional Differences in Communication Process and Outcomes of Requests for Solid Organ Donation. Am J Transplant 2017;17:1620-7. [PMID: 27982508 DOI: 10.1111/ajt.14165] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
67 Passamonti SM, Cannavò A, Panigada M, Trunzo V, Bottazzi A, Longobardi A, Buonocore R, Fiorattini A, Torelli R, Piccolo G, De Feo TM; North Italy Transplant program (NITp) Centers. Donation after circulatory death and liver transplantation: a cohort study. Transpl Int 2021;34:1271-80. [PMID: 34002900 DOI: 10.1111/tri.13919] [Reference Citation Analysis]
68 Jeng LB, Lee SG, Soin AS, Lee WC, Suh KS, Joo DJ, Uemoto S, Joh J, Yoshizumi T, Yang HR. Efficacy and safety of everolimus with reduced tacrolimus in living-donor liver transplant recipients: 12-month results of a randomized multicenter study. Am J Transplant. 2018;18:1435-1446. [PMID: 29237235 DOI: 10.1111/ajt.14623] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
69 Rezaee-zavareh MS, Hesamizadeh K, Sharafi H, Alavian SM. Treatment of Hepatitis C Infection with Direct-Acting Antiviral Agents in Liver-Transplant Patients: A Systematic Review and Meta-Analysis. Hepat Mon 2017;17. [DOI: 10.5812/hepatmon.12324] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
70 Ceresa CDL, Nasralla D, Watson CJE, Butler AJ, Coussios CC, Crick K, Hodson L, Imber C, Jassem W, Knight SR, Mergental H, Ploeg RJ, Pollok JM, Quaglia A, Shapiro AMJ, Weissenbacher A, Friend PJ. Transient Cold Storage Prior to Normothermic Liver Perfusion May Facilitate Adoption of a Novel Technology.Liver Transpl. 2019;25:1503-1513. [PMID: 31206217 DOI: 10.1002/lt.25584] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 8.7] [Reference Citation Analysis]
71 Ahn J, Bhuket T, Mosadeghi S, Frenette C, Liu B, Wong RJ. End-stage liver disease patients with MELD >40 have higher waitlist mortality compared to Status 1A patients. Hepatol Int 2016;10:838-46. [DOI: 10.1007/s12072-016-9735-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
72 Xu G, Jin B, Xian X, Yang H, Zhao H, Du S, Makuuchi M, Pawlik TM, Mao Y. Evolutions in the Management of Hepatocellular Carcinoma over Last 4 Decades: An Analysis from the 100 Most Influential Articles in the Field. Liver Cancer 2021;10:137-50. [PMID: 33977090 DOI: 10.1159/000513412] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
73 Su F, Yu L, Berry K, Liou IW, Landis CS, Rayhill SC, Reyes JD, Ioannou GN. Aging of Liver Transplant Registrants and Recipients: Trends and Impact on Waitlist Outcomes, Post-Transplantation Outcomes, and Transplant-Related Survival Benefit. Gastroenterology. 2016;150:441-453.e6; quiz e16. [PMID: 26522262 DOI: 10.1053/j.gastro.2015.10.043] [Cited by in Crossref: 86] [Cited by in F6Publishing: 76] [Article Influence: 12.3] [Reference Citation Analysis]
74 Van J, Aloman C, Reau N. Potential Bias and Misconceptions in Liver Transplantation for Alcohol- and Obesity-Related Liver Disease. Am J Gastroenterol 2021;116:2089-97. [PMID: 34193797 DOI: 10.14309/ajg.0000000000001349] [Reference Citation Analysis]
75 Cillo U, Bechstein WO, Berlakovich G, Dutkowski P, Lehner F, Nadalin S, Saliba F, Schlitt HJ, Pratschke J. Identifying risk profiles in liver transplant candidates and implications for induction immunosuppression. Transplantation Reviews 2018;32:142-50. [DOI: 10.1016/j.trre.2018.04.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
76 Gruppuso PA, Sanders JA. Regulation of liver development: implications for liver biology across the lifespan. J Mol Endocrinol 2016;56:R115-25. [PMID: 26887388 DOI: 10.1530/JME-15-0313] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
77 Mas VR. Ischemia/reperfusion, does temperature matter? Laboratory perspective. Liver Transpl 2015;21 Suppl 1:S1-5. [PMID: 26334928 DOI: 10.1002/lt.24322] [Reference Citation Analysis]
78 Ebel NH, Hsu EK, Berry K, Horslen SP, Ioannou GN. Disparities in Waitlist and Posttransplantation Outcomes in Liver Transplant Registrants and Recipients Aged 18 to 24 Years: Analysis of the UNOS Database. Transplantation 2017;101:1616-27. [PMID: 28230640 DOI: 10.1097/TP.0000000000001689] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 2.4] [Reference Citation Analysis]
79 Reuben A, Tillman H, Fontana RJ, Davern T, McGuire B, Stravitz RT, Durkalski V, Larson AM, Liou I, Fix O, Schilsky M, McCashland T, Hay JE, Murray N, Shaikh OS, Ganger D, Zaman A, Han SB, Chung RT, Smith A, Brown R, Crippin J, Harrison ME, Koch D, Munoz S, Reddy KR, Rossaro L, Satyanarayana R, Hassanein T, Hanje AJ, Olson J, Subramanian R, Karvellas C, Hameed B, Sherker AH, Robuck P, Lee WM. Outcomes in Adults With Acute Liver Failure Between 1998 and 2013: An Observational Cohort Study. Ann Intern Med. 2016;164:724-732. [PMID: 27043883 DOI: 10.7326/m15-2211] [Cited by in Crossref: 163] [Cited by in F6Publishing: 61] [Article Influence: 27.2] [Reference Citation Analysis]
80 Mah A, Wright A. Infectious Considerations in the Pre-Transplant Evaluation of Cirrhotic Patients Awaiting Orthotopic Liver Transplantation. Curr Infect Dis Rep. 2016;18:4. [PMID: 26743200 DOI: 10.1007/s11908-015-0514-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
81 Alexopoulos SP, Nekrasov V, Cao S, Groshen S, Kaur N, Genyk YS, Matsuoka L. Effects of recipient size and allograft type on pediatric liver transplantation for biliary atresia. Liver Transpl. 2017;23:221-233. [PMID: 27862929 DOI: 10.1002/lt.24675] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
82 Medeiros R, Mattiello R, Corruble E, Sarria EE, Molski C, Brandão A. Cultural Validation of the Transplanted Organ Questionnaire (TOQ) for the Brazilian Population. Ann Hepatol 2018;17:92-7. [PMID: 29311391 DOI: 10.5604/01.3001.0010.7539] [Reference Citation Analysis]
83 Malcolm TL, Chatha K, Breceda AP, Guo E, Friedman DJ, Sabesan VJ, Barsoum WK. The impact of solid organ transplant history on inpatient complications, mortality, length of stay, and cost for primary total shoulder arthroplasty admissions in the United States. J Shoulder Elbow Surg 2018;27:1429-36. [PMID: 29735377 DOI: 10.1016/j.jse.2018.02.064] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
84 Crismale JF, Ahmad J. Expanding the donor pool: Hepatitis C, hepatitis B and human immunodeficiency virus-positive donors in liver transplantation. World J Gastroenterol 2019; 25(47): 6799-6812 [PMID: 31885421 DOI: 10.3748/wjg.v25.i47.6799] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
85 Akamatsu N, Kokudo N. Living Liver Donor Selection and Resection at the University of Tokyo Hospital. Transplantation Proceedings 2016;48:998-1002. [DOI: 10.1016/j.transproceed.2016.01.019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
86 Collins KM, Chapman WC. High-risk liver transplant candidates: An ethical proposal on where to draw the line. Liver Transpl 2015;21:567-9. [DOI: 10.1002/lt.24127] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
87 Yakovenko I, Hyshka E, Tyrrell L, Wild TC. Willingness to participate in hepatitis C vaccine trials among socially marginalized people who use drugs. J Subst Abuse Treat 2019;101:67-71. [PMID: 31174715 DOI: 10.1016/j.jsat.2019.03.010] [Reference Citation Analysis]
88 Thuluvath PJ, Hanish S, Savva Y. Liver Transplantation in Cryptogenic Cirrhosis: Outcome Comparisons Between NASH, Alcoholic, and AIH Cirrhosis. Transplantation 2018;102:656-63. [DOI: 10.1097/tp.0000000000002030] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
89 Miserachs M, Nicholas DB, Otley AR, Ng VL. Health-Related Quality of Life after Pediatric Liver Transplantation: A Qualitative Analysis of the Perspectives of Health Care Providers. Can J Gastroenterol Hepatol 2017;2017:5274923. [PMID: 28713797 DOI: 10.1155/2017/5274923] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
90 Ayloo S, Pentakota SR, Molinari M. Trends of characteristics and outcomes of donors and recipients of deceased donor liver transplantation in the United States: 1990 to 2013. World J Transplantation 2018; 8(5): 167-177 [PMID: 30211025 DOI: 10.5500/wjt.v8.i5.167] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
91 Suri JS, Danford CJ, Patwardhan V, Bonder A. Mortality on the UNOS Waitlist for Patients with Autoimmune Liver Disease. J Clin Med 2020;9:E319. [PMID: 31979326 DOI: 10.3390/jcm9020319] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 Weissenbacher A, Vrakas G, Nasralla D, Ceresa CDL. The future of organ perfusion and re-conditioning.Transpl Int. 2019;32:586-597. [PMID: 30980772 DOI: 10.1111/tri.13441] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
93 Lai JC. Defining the threshold for too sick for transplant. Curr Opin Organ Transplant 2016;21:127-32. [PMID: 26825359 DOI: 10.1097/MOT.0000000000000286] [Cited by in Crossref: 22] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
94 Cleland S, Corredor C, Ye JJ, Srinivas C, McCluskey SA. Massive haemorrhage in liver transplantation: Consequences, prediction and management. World J Transplant 2016; 6(2): 291-305 [PMID: 27358774 DOI: 10.5500/wjt.v6.i2.291] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 30] [Article Influence: 6.7] [Reference Citation Analysis]
95 Rose C, Nickerson P, Delmonico F, Randhawa G, Gill J, Gill JS. Estimation of Potential Deceased Organ Donors in Canada. Transplantation 2016;100:1558-63. [DOI: 10.1097/tp.0000000000000947] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
96 Lorts A, Ryan TD, Matheny Antommaria AH, Lake M, Bucuvalas J. Obtaining consensus regarding international transplantation continues to be difficult for pediatric centers in the United States. Pediatr Transplant 2016;20:774-7. [PMID: 27477950 DOI: 10.1111/petr.12769] [Reference Citation Analysis]
97 Thuluvath AJ, Chen PH, Thuluvath PJ, Kantsevoy S, Savva Y. Poor Survival After Retransplantation in NASH Cirrhosis. Transplantation 2019;103:101-8. [PMID: 29470354 DOI: 10.1097/TP.0000000000002135] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
98 Corman S, Elbasha EH, Michalopoulos SN, Nwankwo C. Cost-Utility of Elbasvir/Grazoprevir in Patients with Chronic Hepatitis C Genotype 1 Infection. Value in Health 2017;20:1110-20. [DOI: 10.1016/j.jval.2017.05.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
99 Nekrasov V, Matsuoka L, Rauf M, Kaur N, Cao S, Groshen S, Alexopoulos SP. National Outcomes of Liver Transplantation for Model for End-Stage Liver Disease Score ≥40: The Impact of Share 35. Am J Transplant 2016;16:2912-24. [DOI: 10.1111/ajt.13823] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
100 Joshi K, Kohli A, Manch R, Gish R. Alcoholic Liver Disease. Clinics in Liver Disease 2016;20:563-80. [DOI: 10.1016/j.cld.2016.02.012] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]
101 Pais R, Barritt AS 4th, Calmus Y, Scatton O, Runge T, Lebray P, Poynard T, Ratziu V, Conti F. NAFLD and liver transplantation: Current burden and expected challenges. J Hepatol. 2016;65:1245-1257. [PMID: 27486010 DOI: 10.1016/j.jhep.2016.07.033] [Cited by in Crossref: 190] [Cited by in F6Publishing: 172] [Article Influence: 31.7] [Reference Citation Analysis]
102 Tang A, Fowler KJ, Chernyak V, Chapman WC, Sirlin CB. LI-RADS and transplantation for hepatocellular carcinoma. Abdom Radiol 2018;43:193-202. [DOI: 10.1007/s00261-017-1210-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
103 Mogul DB, Luo X, Chow EK, Massie AB, Purnell TS, Schwarz KB, Cameron AM, Bridges JFP, Segev DL. Impact of Race and Ethnicity on Outcomes for Children Waitlisted for Pediatric Liver Transplantation. J Pediatr Gastroenterol Nutr 2018;66:436-41. [PMID: 29045352 DOI: 10.1097/MPG.0000000000001793] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 2.7] [Reference Citation Analysis]
104 Campos-Varela I, Agudelo EZ, Sarkar M, Roberts JP, Terrault NA. Use of a hepatitis C virus (HCV) RNA-positive donor in a treated HCV RNA-negative liver transplant recipient. Transpl Infect Dis 2018;20. [PMID: 29125670 DOI: 10.1111/tid.12809] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
105 Yarmush G, Santos L, Yarmush J, Koundinyan S, Saleem M, Nativ NI, Schloss RS, Yarmush ML, Maguire TJ, Berthiaume F. Metabolic Flux Distribution during Defatting of Steatotic Human Hepatoma (HepG2) Cells. Metabolites 2016;6:E1. [PMID: 26742084 DOI: 10.3390/metabo6010001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
106 Ko D, Muehrer RJ, Bratzke LC. Self-Management in Liver Transplant Recipients: A Narrative Review. Prog Transpl 2018;28:100-15. [DOI: 10.1177/1526924818765814] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
107 Domagala P, Takagi K, Ijzermans JN, Polak WG. Grafts from selected deceased donors over 80 years old can safely expand the number of liver transplants: A systematic review and meta-analysis. Transplant Rev (Orlando) 2019;33:209-18. [PMID: 31303351 DOI: 10.1016/j.trre.2019.06.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
108 Bilhartz JL, Drayton AK, Shieck VL. Looking Outside: Summer Camp for Children Who Have Undergone a Solid-Organ Transplant. Crit Care Nurs Q 2016;39:296-303. [PMID: 27254644 DOI: 10.1097/CNQ.0000000000000123] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
109 Kwong A, Kim WR, Mannalithara A, Heo NY, Udompap P, Kim D. Decreasing mortality and disease severity in hepatitis C patients awaiting liver transplantation in the United States. Liver Transpl. 2018;24:735-743. [PMID: 29125676 DOI: 10.1002/lt.24973] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
110 Brown PR, Sadiq O, Weick A, Lenhart A, Elbatta M, Fernandez C, Kutait A, Pompa R, Jafri SM. Acute Kidney Injury in Patients Undergoing Chronic Hepatitis C Virus Treatment With Ledipasvir/Sofosbuvir. Hepatol Commun 2018;2:1172-8. [PMID: 30288472 DOI: 10.1002/hep4.1243] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
111 Kritikos A, Manuel O. Bloodstream infections after solid-organ transplantation. Virulence 2016;7:329-40. [PMID: 26766415 DOI: 10.1080/21505594.2016.1139279] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 7.3] [Reference Citation Analysis]
112 De Carlis R, Di Sandro S, Lauterio A, Ferla F, Dell'Acqua A, Zanierato M, De Carlis L. Successful donation after cardiac death liver transplants with prolonged warm ischemia time using normothermic regional perfusion. Liver Transpl. 2017;23:166-173. [PMID: 27783454 DOI: 10.1002/lt.24666] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 9.2] [Reference Citation Analysis]
113 Cam I, Gencturk M, Lim N, Sharma S, Wong J, Yang M, Golzarian J, Flanagan S, Young S. Alcohol Recidivism Following Transjugular Intrahepatic Portosystemic Shunt Placement: Frequency and Predictive Factors. Cardiovasc Intervent Radiol 2021;44:758-65. [PMID: 33415418 DOI: 10.1007/s00270-020-02754-5] [Reference Citation Analysis]
114 Johannesson L, Järvholm S. Uterus transplantation: current progress and future prospects. Int J Womens Health 2016;8:43-51. [PMID: 26917976 DOI: 10.2147/IJWH.S75635] [Cited by in Crossref: 46] [Cited by in F6Publishing: 10] [Article Influence: 7.7] [Reference Citation Analysis]
115 Emond JC. Measuring access to liver transplantation: An overdue metric for center quality and performance. Journal of Hepatology 2016;64:766-7. [DOI: 10.1016/j.jhep.2016.01.024] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
116 Hsia GSP, Esposito J, da Rocha LA, Ramos SLG, Okamoto OK. Clinical Application of Human Induced Pluripotent Stem Cell-Derived Organoids as an Alternative to Organ Transplantation. Stem Cells Int 2021;2021:6632160. [PMID: 33679987 DOI: 10.1155/2021/6632160] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
117 Joffe AR, Wong K, Bond GY, Khodayari Moez E, Acton BV, Dinu IA, Yap JYK, Robertson CMT; Western Canadian Complex Pediatric Therapies Follow-up Program. Kindergarten-age neurocognitive, functional, and quality-of-life outcomes after liver transplantation at under 6 years of age. Pediatr Transplant 2020;24:e13624. [PMID: 31833183 DOI: 10.1111/petr.13624] [Reference Citation Analysis]
118 Aqel BA, Pungpapong S, Leise M, Werner KT, Chervenak AE, Watt KD, Murphy JL, Ryland K, Keaveny AP, McLemore R, Vargas HE. Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 in patients with cirrhosis. Hepatology. 2015;62:1004-1012. [PMID: 26096332 DOI: 10.1002/hep.27937] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 6.6] [Reference Citation Analysis]
119 Lai JC, Dodge JL, Sen S, Covinsky K, Feng S. Functional decline in patients with cirrhosis awaiting liver transplantation: Results from the functional assessment in liver transplantation (FrAILT) study. Hepatology. 2016;63:574-580. [PMID: 26517301 DOI: 10.1002/hep.28316] [Cited by in Crossref: 112] [Cited by in F6Publishing: 98] [Article Influence: 16.0] [Reference Citation Analysis]
120 Shah RJ, Boin F. Lung Transplantation in Patients With Systemic Sclerosis. Curr Rheumatol Rep 2017;19:23. [PMID: 28386760 DOI: 10.1007/s11926-017-0650-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
121 Burk KS, Singh AK, Vagefi PA, Sahani D. Pretransplantation Imaging Workup of the Liver Donor and Recipient. Radiologic Clinics of North America 2016;54:185-97. [DOI: 10.1016/j.rcl.2015.09.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
122 Jay C, Pugh J, Halff G, Abrahamian G, Cigarroa F, Washburn K. Graft quality matters: Survival after simultaneous liver-kidney transplant according to KDPI. Clin Transplant 2017;31:e12933. [DOI: 10.1111/ctr.12933] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
123 Hong SK, Yi NJ, Kim HS, Ahn SW, Yoon KC, Kim H, Lee KW, Suh KS. Korean Patients Undergoing Deceased Donor Liver Transplantation for Alcoholic Liver Disease Have Non-Inferior Survival Outcomes than for Hepatitis B Virus: a Real-World Experience without Minimum Abstinence before Transplantation. J Korean Med Sci 2017;32:919-25. [PMID: 28480648 DOI: 10.3346/jkms.2017.32.6.919] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
124 Colmenero J, Navasa M. Delta-MELD and survival after liver transplantation: the slope matters. Liver Int 2016;36:949-51. [PMID: 26970536 DOI: 10.1111/liv.13112] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
125 Li S, Zheng X, Li H, Zheng J, Chen X, Liu W, Tai Y, Zhang Y, Wang G, Yang Y. Mesenchymal Stem Cells Ameliorate Hepatic Ischemia/Reperfusion Injury via Inhibition of Neutrophil Recruitment. J Immunol Res. 2018;2018:7283703. [PMID: 30622980 DOI: 10.1155/2018/7283703] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
126 Axelrod DA, Vagefi PA, Roberts JP. The Evolution of Organ Allocation for Liver Transplantation: Tackling Geographic Disparity Through Broader Sharing. Ann Surg 2015;262:224-7. [PMID: 26164429 DOI: 10.1097/SLA.0000000000001340] [Cited by in Crossref: 26] [Cited by in F6Publishing: 4] [Article Influence: 3.7] [Reference Citation Analysis]
127 Zarrinpar A, Lee C, Noguchi E, Yersiz H, Agopian VG, Kaldas FM, Farmer DG, Busuttil RW. A rapid, reproducible, noninvasive predictor of liver graft survival. J Surg Res. 2015;197:183-190. [PMID: 25940156 DOI: 10.1016/j.jss.2015.03.093] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
128 Sakamoto S, Kasahara M, Ogura Y, Inomata Y, Uemoto S; on behalf of the Japanese Liver Transplantation Society. Current status of deceased donor split liver transplantation in Japan. J Hepatobiliary Pancreat Sci 2015;22:837-45. [DOI: 10.1002/jhbp.292] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
129 Toniutto P, Bitetto D, Fornasiere E, Fumolo E. Challenges and future developments in liver transplantation. Minerva Gastroenterol Dietol 2019;65:136-52. [PMID: 30303340 DOI: 10.23736/S1121-421X.18.02529-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
130 VanWagner LB. Asprin and statin use for management of atherosclerotic cardiovascular disease in liver transplant candidates: Are we missing the mark? Liver Transpl 2018;24:865-7. [PMID: 29781097 DOI: 10.1002/lt.25203] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
131 Duarte-Rojo A, Ruiz-Margáin A, Montaño-Loza AJ, Macías-Rodríguez RU, Ferrando A, Kim WR. Exercise and physical activity for patients with end-stage liver disease: Improving functional status and sarcopenia while on the transplant waiting list. Liver Transpl 2018;24:122-39. [PMID: 29024353 DOI: 10.1002/lt.24958] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 18.3] [Reference Citation Analysis]
132 Poordad F, Lawitz E, Gutierrez JA, Guerrero J, Speeg K, Swenson ES. An HCV-positive recipient of an HCV-positive donor liver successfully treated before and immediately after liver transplant with daclatasvir, sofosbuvir, and ribavirin. Clin Case Rep 2017;5:371-5. [PMID: 28396749 DOI: 10.1002/ccr3.841] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
133 Saab S, Jimenez M, Bau S, Goo T, Zhao D, Durazo F, Han S, El Kabany M, Kaldas F, Tong MJ, Busuttil RW. Treating fibrosing cholestatic hepatitis C with sofosbuvir and ribavirin: a matched analysis. Clin Transplant 2015;29:813-9. [PMID: 26147216 DOI: 10.1111/ctr.12584] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
134 Mogul DB, Luo X, Bowring MG, Chow EK, Massie AB, Schwarz KB, Cameron AM, Bridges JFP, Segev DL. Fifteen-Year Trends in Pediatric Liver Transplants: Split, Whole Deceased, and Living Donor Grafts. J Pediatr 2018;196:148-153.e2. [PMID: 29307689 DOI: 10.1016/j.jpeds.2017.11.015] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 9.0] [Reference Citation Analysis]
135 Bilhartz JL, Shieck VL. Pediatric Liver Transplantation: Unique Concerns for the Critical Care Team. Crit Care Nurs Q 2016;39:281-95. [PMID: 27254643 DOI: 10.1097/CNQ.0000000000000121] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
136 Giakoustidis AE, Giakoustidis DE. Immunosuppression strategies in liver transplantation patient; patients with hepatocellular carcinoma. Immunotherapy 2017;9:197-206. [PMID: 28128716 DOI: 10.2217/imt-2016-0110] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
137 Sanders JA. Late Gestation Fetal Hepatocytes for Liver Repopulation in the Rat. Methods Mol Biol 2017;1506:45-60. [PMID: 27830544 DOI: 10.1007/978-1-4939-6506-9_3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
138 Mysore KR, Himes RW, Rana A, Teruya J, Desai MS, Srivaths PR, Zaruca K, Calvert A, Guffey D, Minard CG, Morita E, Hensch L, Losos M, Kostousov V, Hui SR, Orange JS, Goss JA, Nicholas SK. ABO-incompatible deceased donor pediatric liver transplantation: Novel titer-based management protocol and outcomes. Pediatr Transplant 2018;22:e13263. [PMID: 30070010 DOI: 10.1111/petr.13263] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
139 Åberg F, Nordin A, Mäkisalo H, Isoniemi H. Who is too healthy and who is too sick for liver transplantation: external validation of prognostic scores and survival-benefit estimation. Scand J Gastroenterol 2015;50:1144-51. [PMID: 25865580 DOI: 10.3109/00365521.2015.1028992] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
140 Shetty A, Buch A, Saab S. Use of Hepatitis C-Positive Liver Grafts in Hepatitis C-Negative Recipients. Dig Dis Sci 2019;64:1110-8. [PMID: 30560331 DOI: 10.1007/s10620-018-5404-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
141 Collin de l'Hortet A, Takeishi K, Guzman-Lepe J, Handa K, Matsubara K, Fukumitsu K, Dorko K, Presnell SC, Yagi H, Soto-Gutierrez A. Liver-Regenerative Transplantation: Regrow and Reset. Am J Transplant 2016;16:1688-96. [PMID: 26699680 DOI: 10.1111/ajt.13678] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 4.7] [Reference Citation Analysis]
142 Åberg F. From prolonging life to prolonging working life: Tackling unemployment among liver-transplant recipients. World J Gastroenterol 2016; 22(14): 3701-3711 [PMID: 27076755 DOI: 10.3748/wjg.v22.i14.3701] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
143 Leung KK, Deeb M, Hirschfield GM. Review article: pathophysiology and management of primary biliary cholangitis. Aliment Pharmacol Ther. [DOI: 10.1111/apt.16023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
144 Alferink LJM, Oey RC, Hansen BE, Polak WG, van Buuren HR, de Man RA, Schurink CAM, Metselaar HJ. The impact of infections on delisting patients from the liver transplantation waiting list. Transpl Int 2017;30:807-16. [PMID: 28403563 DOI: 10.1111/tri.12965] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
145 Ezekian B, Mulvihill MS, Freischlag K, Yerokun BA, Davis RP, Hartwig MG, Knechtle SJ, Barbas AS. Elevated HbA1c in donor organs from patients without a diagnosis of diabetes portends worse liver allograft survival. Clin Transplant 2017;31. [PMID: 28667782 DOI: 10.1111/ctr.13047] [Reference Citation Analysis]
146 Kalisvaart M, de Haan JE, Polak WG, Metselaar HJ, Wijnhoven BPL, IJzermans JNM, de Jonge J. Comparison of Postoperative Outcomes Between Donation After Circulatory Death and Donation After Brain Death Liver Transplantation Using the Comprehensive Complication Index. Ann Surg. 2017;266:772-778. [PMID: 28742700 DOI: 10.1097/sla.0000000000002419] [Cited by in Crossref: 34] [Cited by in F6Publishing: 13] [Article Influence: 6.8] [Reference Citation Analysis]
147 Ng VL, Mazariegos GV, Kelly B, Horslen S, Mcdiarmid SV, Magee JC, Loomes KM, Fischer RT, Sundaram SS, Lai JC, Te HS, Bucuvalas JC. Barriers to ideal outcomes after pediatric liver transplantation. Pediatr Transplant 2019;23. [DOI: 10.1111/petr.13537] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
148 Santopaolo F, Lenci I, Milana M, Manzia TM, Baiocchi L. Liver transplantation for hepatocellular carcinoma: Where do we stand? World J Gastroenterol 2019; 25(21): 2591-2602 [PMID: 31210712 DOI: 10.3748/wjg.v25.i21.2591] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 18] [Article Influence: 7.3] [Reference Citation Analysis]
149 Cui C, Enosawa S, Matsunari H, Nagashima H, Umezawa A. Natural Flavonol, Myricetin, Enhances the Function and Survival of Cryopreserved Hepatocytes In Vitro and In Vivo. Int J Mol Sci 2019;20:E6123. [PMID: 31817281 DOI: 10.3390/ijms20246123] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
150 Beijert I, Mert S, Huang V, Karimian N, Geerts S, Hafiz EOA, Markmann JF, Yeh H, Porte RJ, Uygun K. Endothelial Dysfunction in Steatotic Human Donor Livers: A Pilot Study of the Underlying Mechanism During Subnormothermic Machine Perfusion. Transplant Direct 2018;4:e345. [PMID: 29796416 DOI: 10.1097/TXD.0000000000000779] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
151 Reddy SS, Civan JM. From Child-Pugh to Model for End-Stage Liver Disease. Medical Clinics of North America 2016;100:449-64. [DOI: 10.1016/j.mcna.2015.12.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
152 Young K, Liu B, Bhuket T, Gish RG, Wong RJ. Improved liver transplant waitlist mortality and lower risk of disease progression among chronic hepatitis C patients awaiting liver transplantation after the introduction of direct-acting antiviral therapies in the United States. J Viral Hepat. 2019;26:350-361. [PMID: 30412318 DOI: 10.1111/jvh.13039] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
153 Ceresa CDL, Nasralla D, Coussios CC, Friend PJ. The case for normothermic machine perfusion in liver transplantation. Liver Transpl 2018;24:269-75. [PMID: 29272051 DOI: 10.1002/lt.25000] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
154 Dirchwolf M, Dodge JL, Gralla J, Bambha KM, Nydam T, Hung KW, Rosen HR, Feng S, Terrault NA, Biggins SW. The corrected donor age for hepatitis C virus-infected liver transplant recipients. Liver Transpl. 2015;21:1022-1030. [PMID: 26074140 DOI: 10.1002/lt.24194] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
155 Curry MP. Direct acting antivirals for decompensated cirrhosis. Efficacy and safety are now established. J Hepatol. 2016;64:1206-1207. [PMID: 26948496 DOI: 10.1016/j.jhep.2016.02.041] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
156 Newland DM, Edwards AR, Hall RC, Maxwell PR. Positive Impact of a Pilot Pharmacist-Run Diabetes Pharmacotherapy Clinic in Solid-Organ Transplant Recipients. Diabetes Spectr 2018;31:167-76. [PMID: 29773937 DOI: 10.2337/ds17-0029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
157 Livingstone SM, Andres A, Shapiro AM, Kneteman NN, Bigam DL. Diaphragmatic Hernia After Living Donor Right Hepatectomy: Proposal for a Screening Protocol. Transplant Direct 2016;2:e84. [PMID: 27830178 DOI: 10.1097/TXD.0000000000000596] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
158 Mohammad S, Kaurs E, Aguirre VP, Varni JW, Alonso EM. Health-related Quality of Life in Infants With Chronic Liver Disease. J Pediatr Gastroenterol Nutr 2016;62:751-6. [PMID: 26628442 DOI: 10.1097/MPG.0000000000001054] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
159 Saab S, Rheem J, Jimenez MA, Fong TM, Mai MH, Kachadoorian CA, Esmailzadeh NL, Bau SN, Kang S, Ramirez SD, Grotts J, Choi G, Durazo FA, El-Kabany MM, Han SB, Busuttil RW. Effectiveness of Ledipasvir/Sofosbuvir with/without Ribavarin in Liver Transplant Recipients with Hepatitis C. J Clin Transl Hepatol 2017;5:101-8. [PMID: 28660147 DOI: 10.14218/JCTH.2016.00070] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
160 Khayat A, Vitola B. Prevalence and Clinical Significance of Autoantibodies in Children with Overweight and Obesity with Nonalcoholic Fatty Liver Disease. J Pediatr 2021;239:155-60. [PMID: 34454951 DOI: 10.1016/j.jpeds.2021.08.041] [Reference Citation Analysis]
161 Welker MW, Zeuzem S. Pre- and Post-Transplant Antiviral Therapy (HBV, HCV). Visc Med 2016;32:105-9. [PMID: 27413727 DOI: 10.1159/000445152] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
162 Wu SZ, Jiang P, DeCaro JE, Bordeaux JS. A qualitative systematic review of the efficacy of sun protection education in organ transplant recipients. J Am Acad Dermatol 2016;75:1238-1244.e5. [PMID: 27476105 DOI: 10.1016/j.jaad.2016.06.031] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
163 Garaix F, Stern M, Lamy FX, Dubel L, Kamar N. Tacrolimus Granules for Oral Suspension as Post-Transplant Immunosuppression in Routine Medical Practice in France: The OPTIMOD Study. Ann Transplant 2018;23:561-71. [PMID: 30093607 DOI: 10.12659/AOT.908522] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
164 Hernández D, Muriel A, Abraira V. Current state of clinical end-points assessment in transplant: Key points. Transplant Rev (Orlando) 2016;30:92-9. [PMID: 26948088 DOI: 10.1016/j.trre.2016.02.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
165 Kensinger CD, Feurer ID, Karp SJ. An Outcome-Based Approach to Assign MELD Exception Points for Patients With Hepatocellular Cancer. Transplantation 2017;101:2056-61. [DOI: 10.1097/tp.0000000000001812] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
166 Akateh C, Beal EW, Whitson BA, Black SM. Normothermic Ex-vivo Liver Perfusion and the Clinical Implications for Liver Transplantation. J Clin Transl Hepatol 2018;6:276-82. [PMID: 30271739 DOI: 10.14218/JCTH.2017.00048] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
167 Bowring MG, Kucirka LM, Massie AB, Luo X, Cameron A, Sulkowski M, Rakestraw K, Gurakar A, Kuo I, Segev DL, Durand CM. Changes in Utilization and Discard of Hepatitis C-Infected Donor Livers in the Recent Era. Am J Transplant. 2017;17:519-527. [PMID: 27456927 DOI: 10.1111/ajt.13976] [Cited by in Crossref: 64] [Cited by in F6Publishing: 63] [Article Influence: 10.7] [Reference Citation Analysis]
168 Parent B, Caplan AL. Fair is fair: We must re-allocate livers for transplant. BMC Med Ethics 2017;18:26. [PMID: 28381305 DOI: 10.1186/s12910-017-0186-9] [Cited by in Crossref: 9] [Article Influence: 1.8] [Reference Citation Analysis]
169 Dorr CR, Freedman BI, Hicks PJ, Brown WM, Russell GB, Julian BA, Pastan SO, Gautreaux MD, Muthusamy A, Chinnakotla S, Hauptfeld V, Bray RA, Kirk AD, Divers J, Israni AK. Deceased-Donor Apolipoprotein L1 Renal-Risk Variants Have Minimal Effects on Liver Transplant Outcomes. PLoS One 2016;11:e0152775. [PMID: 27054572 DOI: 10.1371/journal.pone.0152775] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
170 Mysore KR, Ghobrial RM, Kannanganat S, Minze LJ, Graviss EA, Nguyen DT, Perez KK, Li XC. Longitudinal assessment of T cell inhibitory receptors in liver transplant recipients and their association with posttransplant infections. Am J Transplant 2018;18:351-63. [PMID: 29068155 DOI: 10.1111/ajt.14546] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
171 Addolorato G, Bataller R, Burra P, DiMartini A, Graziadei I, Lucey MR, Mathurin P, OʼGrady J, Pageaux G, Berenguer M. Liver Transplantation for Alcoholic Liver Disease. Transplantation 2016;100:981-7. [PMID: 26985744 DOI: 10.1097/TP.0000000000001156] [Cited by in Crossref: 39] [Cited by in F6Publishing: 14] [Article Influence: 7.8] [Reference Citation Analysis]
172 Linecker M, Krones T, Berg T, Niemann CU, Steadman RH, Dutkowski P, Clavien PA, Busuttil RW, Truog RD, Petrowsky H. Potentially inappropriate liver transplantation in the era of the "sickest first" policy - A search for the upper limits. J Hepatol. 2018;68:798-813. [PMID: 29133246 DOI: 10.1016/j.jhep.2017.11.008] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 7.4] [Reference Citation Analysis]
173 Squires JE, Rudnick DA, Hardison RM, Horslen S, Ng VL, Alonso EM, Belle SH, Squires RH. Liver Transplant Listing in Pediatric Acute Liver Failure: Practices and Participant Characteristics. Hepatology 2018;68:2338-47. [PMID: 30070372 DOI: 10.1002/hep.30116] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
174 Gielis EM, Ledeganck KJ, De Winter BY, Del Favero J, Bosmans J, Claas FHJ, Abramowicz D, Eikmans M. Cell-Free DNA: An Upcoming Biomarker in Transplantation: Cell-Free DNA as a Transplantation Biomarker. American Journal of Transplantation 2015;15:2541-51. [DOI: 10.1111/ajt.13387] [Cited by in Crossref: 93] [Cited by in F6Publishing: 78] [Article Influence: 13.3] [Reference Citation Analysis]
175 Bruinsma BG, Avruch JH, Sridharan GV, Weeder PD, Jacobs ML, Crisalli K, Amundsen B, Porte RJ, Markmann JF, Uygun K, Yeh H. Peritransplant Energy Changes and Their Correlation to Outcome After Human Liver Transplantation. Transplantation 2017;101:1637-44. [PMID: 28230641 DOI: 10.1097/TP.0000000000001699] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
176 Wei S, Cao D, Liu Z, Li J, Wu H, Gong J, Liu Y, Wu Y. Dysfunctional immunoregulation in human liver allograft rejection associated with compromised galectin-1/CD7 pathway function. Cell Death Dis 2018;9:293. [PMID: 29463785 DOI: 10.1038/s41419-017-0220-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
177 Ember KJI, Hunt F, Jamieson LE, Hallett JM, Esser H, Kendall TJ, Clutton RE, Gregson R, Faulds K, Forbes SJ, Oniscu GC, Campbell CJ. Noninvasive Detection of Ischemic Vascular Damage in a Pig Model of Liver Donation After Circulatory Death. Hepatology 2021;74:428-43. [PMID: 33420756 DOI: 10.1002/hep.31701] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
178 Civan JM. Liver Transplantation for HCC: The Milan Criteria. In: Doria C, editor. Contemporary Liver Transplantation. Cham: Springer International Publishing; 2016. pp. 1-19. [DOI: 10.1007/978-3-319-05543-5_11-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
179 Tchilikidi KY. Liver graft preservation methods during cold ischemia phase and normothermic machine perfusion. World J Gastrointest Surg 2019; 11(3): 126-142 [PMID: 31057698 DOI: 10.4240/wjgs.v11.i3.126] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
180 Wieland A, Everson GT. Co-existing Hepatitis C and Alcoholic Liver Disease: A Diminishing Indication for Liver Transplantation? Alcohol Alcohol 2018;53:187-92. [PMID: 29329373 DOI: 10.1093/alcalc/agx101] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
181 Lutfi R, Abulebda K, Nitu ME, Molleston JP, Bozic MA, Subbarao G. Intensive Care Management of Pediatric Acute Liver Failure. J Pediatr Gastroenterol Nutr. 2017;64:660-670. [PMID: 27741059 DOI: 10.1097/mpg.0000000000001441] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
182 Piao D, Ritchey JW, Holyoak GR, Wall CR, Sultana N, Murray JK, Bartels KE. In vivo percutaneous reflectance spectroscopy of fatty liver development in rats suggests that the elevation of the scattering power is an early indicator of hepatic steatosis. J Innov Opt Health Sci 2018;11:1850019. [DOI: 10.1142/s1793545818500190] [Cited by in Crossref: 6] [Article Influence: 1.5] [Reference Citation Analysis]
183 Ceresa CDL, Nasralla D, Knight S, Friend PJ. Cold storage or normothermic perfusion for liver transplantation: probable application and indications. Curr Opin Organ Transplant. 2017;22:300-305. [PMID: 28301388 DOI: 10.1097/mot.0000000000000410] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 3.8] [Reference Citation Analysis]
184 Kilambi V, Mehrotra S. Improving Liver Allocation Using Optimized Neighborhoods. Transplantation 2017;101:350-9. [DOI: 10.1097/tp.0000000000001505] [Cited by in Crossref: 16] [Cited by in F6Publishing: 1] [Article Influence: 3.2] [Reference Citation Analysis]
185 Mazzaferro V, Sposito C, Zhou J, Pinna AD, De Carlis L, Fan J, Cescon M, Di Sandro S, Yi-Feng H, Lauterio A, Bongini M, Cucchetti A. Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma. Gastroenterology. 2018;154:128-139. [PMID: 28989060 DOI: 10.1053/j.gastro.2017.09.025] [Cited by in Crossref: 178] [Cited by in F6Publishing: 170] [Article Influence: 35.6] [Reference Citation Analysis]
186 Nishii K, Reese G, Moran EC, Sparks JL. Multiscale computational model of fluid flow and matrix deformation in decellularized liver. J Mech Behav Biomed Mater 2016;57:201-14. [PMID: 26722987 DOI: 10.1016/j.jmbbm.2015.11.033] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
187 Ferrer-Fàbrega J, Sampson-Dávila J, Forner A, Sapena V, Díaz A, Vilana R, Navasa M, Fondevila C, Miquel R, Ayuso C, García-Valdecasas JC, Bruix J, Reig M, Fuster J. Limited tumour progression beyond Milan criteria while on the waiting list does not result in unacceptable impairment of survival. J Hepatol 2021:S0168-8278(21)00435-9. [PMID: 34171433 DOI: 10.1016/j.jhep.2021.06.015] [Reference Citation Analysis]
188 Saxena V, Lai JC. Kidney Failure and Liver Allocation: Current Practices and Potential Improvements. Adv Chronic Kidney Dis. 2015;22:391-398. [PMID: 26311601 DOI: 10.1053/j.ackd.2015.05.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
189 Gao G, Cui X. Three-dimensional bioprinting in tissue engineering and regenerative medicine. Biotechnol Lett 2016;38:203-11. [PMID: 26466597 DOI: 10.1007/s10529-015-1975-1] [Cited by in Crossref: 117] [Cited by in F6Publishing: 94] [Article Influence: 16.7] [Reference Citation Analysis]
190 Aby E, Jimenez MA, Grotts JF, Agopian V, French SW, Busuttil RW, Saab S. Diminishing Use of Liver Biopsy among Liver Transplant Recipients for Hepatitis C. J Clin Transl Hepatol 2017;5:197-202. [PMID: 28936400 DOI: 10.14218/JCTH.2016.00073] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
191 An T, Dean M, Flower R, Tatzenko T, Chan HT, Kiely P, Faddy HM. Understanding occult hepatitis C infection. Transfusion 2020;60:2144-52. [PMID: 33460181 DOI: 10.1111/trf.16006] [Reference Citation Analysis]
192 Saab S, Challita YP, Najarian LM, Guo R, Saggi SS, Choi G. Hepatitis C Screening: Barriers to Linkage to Care. J Clin Transl Hepatol. 2019;7:226-231. [PMID: 31608214 DOI: 10.14218/jcth.2018.00063] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
193 Perumpail RB, Yoo ER, Cholankeril G, Hogan L, Deis M, Concepcion WC, Bonham CA, Younossi ZM, Wong RJ, Ahmed A. Underutilization of Living Donor Liver Transplantation in the United States: Bias against MELD 20 and Higher. J Clin Transl Hepatol 2016;4:169-74. [PMID: 27777886 DOI: 10.14218/JCTH.2016.00029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
194 Wingfield LR, Ceresa C, Thorogood S, Fleuriot J, Knight S. Using Artificial Intelligence for Predicting Survival of Individual Grafts in Liver Transplantation: A Systematic Review. Liver Transpl. 2020;26:922-934. [PMID: 32274856 DOI: 10.1002/lt.25772] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
195 Dolgin NH, Martins PN, Movahedi B, Lapane KL, Anderson FA, Bozorgzadeh A. Functional status predicts postoperative mortality after liver transplantation. Clin Transplant. 2016;30:1403-1410. [PMID: 27439897 DOI: 10.1111/ctr.12808] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 7.7] [Reference Citation Analysis]
196 Carey EJ, Ali AH, Lindor KD. Primary biliary cirrhosis. Lancet. 2015;386:1565-1575. [PMID: 26364546 DOI: 10.1016/s0140-6736(15)00154-3] [Cited by in Crossref: 277] [Cited by in F6Publishing: 121] [Article Influence: 39.6] [Reference Citation Analysis]
197 Mas V, Archer KJ, Maluf D. The High-Risk Age Window After Pediatric Liver Transplantation: Modeling Allograft Loss Using Mathematical Tools. Transplantation 2016;100:487-8. [PMID: 26569068 DOI: 10.1097/TP.0000000000001010] [Reference Citation Analysis]
198 Piao D, Sultana N, Holyoak GR, Ritchey JW, Wall CR, Murray JK, Bartels KE. In vivo assessment of diet-induced rat hepatic steatosis development by percutaneous single-fiber spectroscopy detects scattering spectral changes due to fatty infiltration. J Biomed Opt 2015;20:117002. [DOI: 10.1117/1.jbo.20.11.117002] [Cited by in Crossref: 9] [Article Influence: 1.3] [Reference Citation Analysis]
199 Ursic-Bedoya J, Faure S, Donnadieu-Rigole H, Pageaux GP. Liver transplantation for alcoholic liver disease: Lessons learned and unresolved issues. World J Gastroenterol 2015; 21(39): 10994-11002 [PMID: 26494956 DOI: 10.3748/wjg.v21.i39.10994] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
200 Gordon EJ, Mullee J, Skaro A, Baker T. Live liver donors' information needs: A qualitative study of practical implications for informed consent. Surgery 2016;160:671-82. [PMID: 27269968 DOI: 10.1016/j.surg.2016.04.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
201 Anand AC. Potential Liver Transplant Recipients with Hepatitis C: Should They Be Treated Before or After Transplantation? J Clin Exp Hepatol. 2017;7:42-54. [PMID: 28348470 DOI: 10.1016/j.jceh.2017.01.116] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
202 Hart A, Schladt DP, Zeglin J, Pyke J, Kim WR, Lake JR, Roberts JP, Hirose R, Mulligan DC, Kasiske BL, Snyder JJ, Israni AK. Predicting Outcomes on the Liver Transplant Waiting List in the United States: Accounting for Large Regional Variation in Organ Availability and Priority Allocation Points. Transplantation 2016;100:2153-9. [PMID: 27490411 DOI: 10.1097/TP.0000000000001384] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]